OXFORD IMMUNOTEC GLOBAL LIMITED

Active Abingdon

Manufacture of pharmaceutical preparations

0 employees website.com
Manufacture of pharmaceutical preparations
O

OXFORD IMMUNOTEC GLOBAL LIMITED

Manufacture of pharmaceutical preparations

Founded 16 Aug 2013 Active Abingdon, England 0 employees website.com
Manufacture of pharmaceutical preparations

Previous Company Names

OXFORD IMMUNOTEC GLOBAL PLC 16 Aug 2013 — 17 Mar 2021
Accounts Submitted 7 Jan 2026 Next due 30 Sept 2026 4 months remaining
Confirmation Submitted 1 Sept 2025 Next due 28 Aug 2026 3 months remaining
Net assets £113M £199K 2024 year on year
Total assets £113M £277K 2024 year on year
Total Liabilities £100K £78K 2024 year on year
Charges 8
8 satisfied

Contact & Details

Contact

Registered Address

143 Park Drive Milton Abingdon OX14 4SE England

Full company profile for OXFORD IMMUNOTEC GLOBAL LIMITED (08654254), an active company based in Abingdon, England. Incorporated 16 Aug 2013. Manufacture of pharmaceutical preparations. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 30 Dec → 29 Dec 2024
Type full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 4 months remaining

Net Assets, Total Assets & Total Liabilities (2021–2024)

Cash in Bank

£1.71M

Increased by £1.16M (+209%)

Net Assets

£113.28M

Increased by £199.31k (+0%)

Total Liabilities

£99.83k

Increased by £77.85k (+354%)

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2024
29 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

34 Allotments 9,751,216 Shares £625.84m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
27 Mar 202016,593£111.256£0.007
27 Mar 202016,593£111.256£0.007
7 Jan 202016,564£111.062£0.007
16 Dec 201941,234£276.474£0.007
16 Oct 201912,352£82.82£0.007

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Perkinelmer (uk) Holdings Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 7 Mar 2021
Nature of Control
  • Ownership Of Shares 75 To 100 Percent

Group Structure

Group Structure

OXFORD IMMUNOTEC GLOBAL LIMITED Current Company

Charges

Charges

8 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
7 Jan 2026AccountsAnnual accounts made up to 29 Dec 2024
1 Sept 2025Confirmation StatementConfirmation statement made on 14 Aug 2025 with no updates
7 Mar 2025AccountsAnnual accounts made up to 31 Dec 2023
27 Feb 2025AccountsAnnual accounts made up to 31 Dec 2023
5 Nov 2024Confirmation StatementSecond Filing Of Confirmation Statement With Made Up Date
7 Jan 2026 Accounts

Annual accounts made up to 29 Dec 2024

1 Sept 2025 Confirmation Statement

Confirmation statement made on 14 Aug 2025 with no updates

7 Mar 2025 Accounts

Annual accounts made up to 31 Dec 2023

27 Feb 2025 Accounts

Annual accounts made up to 31 Dec 2023

5 Nov 2024 Confirmation Statement

Second Filing Of Confirmation Statement With Made Up Date

Recent Activity

Latest Activity

Annual accounts made up to 29 Dec 2024

4 months ago on 7 Jan 2026

Confirmation statement made on 14 Aug 2025 with no updates

8 months ago on 1 Sept 2025

Annual accounts made up to 31 Dec 2023

1 years ago on 7 Mar 2025

Annual accounts made up to 31 Dec 2023

1 years ago on 27 Feb 2025

Second Filing Of Confirmation Statement With Made Up Date

1 years ago on 5 Nov 2024